About this episode
Mifepristone revolutionized abortion access in America, so much that, two years after the fall of Roe v. Wade, abortions in the United States are up.
But now “Mife” is taking its turn in the crosshairs of the anti-abortion movement, facing a challenge before the Supreme Court that could cut off access to the drug. Can it survive this challenge? And, if so, would that mean the pro-choice movement is quietly winning the fight for abortion access in America?
This week on “How We Got Here,” Hysteria’s Erin Ryan and Offline’s Max Fisher tell the story of how Mifepristone became the anti-abortion movement’s #1 enemy and the new lows that movement has had to go to get this challenge before the court.
SOURCES:
Timeline of the Supreme Court’s mifepristone abortion pill ruling | CNN Politics
One in Six Abortions Is Done With Pills Prescribed Online, Data Shows - The New York Times
Abortion Shield Laws: A New War Between the States - The New York Times
Challenging Abortion, Again - The New York Times
Despite State Bans, Legal Abortions Didn’t Fall Nationwide in Year After Dobbs
Abortion Bans Across the Country: Tracking Restrictions by State - The New York Times
Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval Authority - The New York Times
The many lives of mifepristone: Multi-glandular exaptation of an endocrine molecule - PMC.
NYT Archive: DRUG MAKER STOPS ALL DISTRIBUTION OF ABORTION PILL
Get every episode summarized
Each time What A Day publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
